This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Antonipillai, I. Articles by Horton, R. Search for Related Content PubMed PubMed Citation Articles by Antonipillai, I. Articles by Horton, R.

Hypertension, Vol 10, 61-66, Copyright © 1987 by American Heart Association

ARTICLES

The inhibitory role of 12- and 15-lipoxygenase products on renin release

I Antonipillai, JL Nadler, EC Robin and R Horton

Release of arachidonic acid from membrane phospholipids is a limiting step in the synthesis of both cyclooxygenase products and lipoxygenase products. The direct effects of prostacyclin and some lipoxygenase products on renin release were studied using rat renal cortical slices. Prostacyclin, at concentrations of 10(-5) M, stimulated renin secretion, but this effect was short-lived. Leukotrienes or their precursor, 5-hydroperoxyeicosatetraenoic acid, did not affect basal renin release. In contrast, 10(-9) M 12-hydroperoxyeicosatetraenoic acid and 10(-8) M 12-hydroxyeicosatetraenoic acid were potent inhibitors of renin secretion. Similarly, 15- hydroperoxyeicosatetraenoic acid and its hydroxy derivative, 15- hydroxyeicosatetraenoic acid, at somewhat higher molar concentrations (10(-6) M) also reduced basal renin. These studies confirm prostacyclin as a potential renin secretagogue; however, its action in vitro is transient, probably because of its rapid degradation. Our studies provide new evidence that products of the 12-lipoxygenase and 15- lipoxygenase pathways, reported to be present in renal vascular tissue, are potent inhibitors of renin secretion and much more active on a molar basis on renin secretion than is prostacyclin. These studies suggest the potential presence of a dual system of stimulation and suppression that may regulate renin secretion in normal and clinical states.

This article has been cited by other articles:

				S. W. Reinhold, H. Vitzthum, T. Filbeck, K. Wolf, C. Lattas, G. A. J. Riegger, A. Kurtz, and B. K. Kramer Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat nephron Am J Physiol Renal Physiol, April 1, 2006; 290(4): F864 - F872. [Abstract] [Full Text] [PDF]

				C. E. Giammattei, J. W. Strandhoy, and J. C. Rose Regulation of in vitro renin secretion by ANG II feedback manipulation in vivo in the ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1230 - R1238. [Abstract] [Full Text] [PDF]

				O. Ito and R. J. Roman Regulation of P-450 4A activity in the glomerulus of the rat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1749 - R1757. [Abstract] [Full Text] [PDF]

				E. S. Kisch, A. Jaffe, E. Knoll, and N. Stern Role of the Lipoxygenase Pathway in Angiotensin II–Induced Vasoconstriction in the Human Placenta Hypertension, March 1, 1997; 29(3): 796 - 801. [Abstract] [Full Text]

				J.-L. Gu, D. Veerapanane, J. Rossi, R. Natarajan, L. Thomas, and J. Nadler Ribozyme-Mediated Inhibition of Expression of Leukocyte-type 12-Lipoxygenase in Porcine Aortic Vascular Smooth Muscle Cells Circ. Res., July 1, 1995; 77(1): 14 - 20. [Abstract] [Full Text]